Shop
Menu
Shop
Background 2
P ENCK 1

New clinical study on

1714-Serenitas®

 

Professor Paul Enck and colleagues conduct new clinical study using 1714-Serenitas®,the bacterial culture in Zenflore®.

Professor Paul Enck and his group at University of Tübingen (Germany) and The Alimentary Health Group1 have conducted a new clinical study, which has just been published online in the American Journal of Gastroenterology.

Professor Enck’s group are renowned researchers in the gut-brain axis.

   Logo_PrecisionBiotics_430x65px.png

1 - The Alimentary Health Group is a parent company of PrecisionBioticsTM

Commenting on this new study, Professor Enck said:

Commenting on this new study, Professor Enck said:

‘As researchers in the placebo effect, we have been sceptical about many of the claims made about bacterial cultures and the gut-brain axis. We have significant experience in the placebo effect and so our team designed a comprehensive study to assess this strain.
We think the results are novel and innovative and provide a scientific basis to assess the true impact of specific bacterial strains on the brain.’ 

 

Read the study here

Paul Enck Study